Status:

COMPLETED

Safety and Pharmacokinetic Study of Inhaled Esketamine in Healthy Volunteers

Lead Sponsor:

Celon Pharma SA

Collaborating Sponsors:

National Center for Research and Development, Poland

Conditions:

Healthy Volunteers

Eligibility:

All Genders

18-55 years

Phase:

PHASE1

Brief Summary

The planned study is to determine the pharmacokinetic properties of Esketamine and safety assessment with inhaled Esketamine after different number of inhalations and different dosing sequences within...

Detailed Description

This is to be one-centre, single ascending dose and double-blind placebo controlled multiple dose three part study of Esketamine DPI (dry powder inhaler) in healthy volunteers. PART A is a single dos...

Eligibility Criteria

Inclusion

  • Caucasian female or male,
  • Age: 18-55 years old, inclusive,
  • Body-mass index (BMI): ≥18.5 kg/m\^2 and \<29.9 kg/m\^2
  • Non-smoker and nonuser of tobacco products for at least 1 year before screening,
  • Physical examination without any clinically relevant abnormality,
  • Laboratory values not clinically significant,
  • Volunteer (or his/her partner) of childbearing potential willingness to use acceptable forms of contraception.

Exclusion

  • Known allergy or hypersensitivity to ketamine or its derivates and/or to any study product excipients,
  • Any known significant current or past acute or chronic disease or condition,
  • Participation in other clinical trial within 90 days preceding the screening,
  • Blood drawn within 30 days prior to inclusion to the study (more or equal to 300mL),
  • Positive results from pregnancy test for female participants,
  • Lactation in women participants,
  • Hypotension or hypertension in medical history,
  • Narcotic, alcohol addiction or abuse,
  • Participant who adhere to a special diet (e.g. low calories, vegetarian).

Key Trial Info

Start Date :

December 9 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 19 2018

Estimated Enrollment :

63 Patients enrolled

Trial Details

Trial ID

NCT03407872

Start Date

December 9 2017

End Date

June 19 2018

Last Update

July 12 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

BioResearch Group Sp. z o.o.

Kajetany, Poland